Scientists to progress glioblastoma antibody into clinical trials

Scientists of Helmholtz Zentrum München and the Munich University Hospital (LMU) are developing a novel antibody to treat glioblastoma.

Click on this link for more information.

Guideline on good pharmacovigilance practices (GVP) - Module VI – Collection, management and submiss

Guideline on requirements for the production and control of immunological veterinary medicinal produ

What’s new in Pharmacovigilance? QPPV update (Issue 2, July 2017)